FDNA provides commercial pharma and biotech companies with advanced tools to understand, interact with, and sell into the rare disease and genetic disease markets.

Identify and communicate with clinical sites who see targeted patient groups with commercial campaigns, such as, drug education, polls and promotional outreach to support post-market activities.

Get Started

Contact Us

2000+ institutions in 100+ countries

Targeted Clinician Identification

  • Identify clinicians based on access to eligible patients
  • Global or geotargeted

Clinician Communications

  • Educate clinicians on post-market drugs and approvals
  • Promote brand and opportunities to clinicians
  • Poll clinical institutions to gain insights
  • Email, phone and in-app direct communications channels

Phase 4 Clinical Trial Recruitment Services

  • Enrollment feasibility
  • Site identification
  • Patient recruitment services

Business Development and Market Pre-Assessment

  • Population data for syndromes and healthcare access
  • Refinement by criteria such as demographics, phenotypes and genetics